These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23279177)

  • 1. Neurochemistry of schizophrenia: the contribution of neuroimaging postmortem pathology and neurochemistry in schizophrenia.
    Dean B
    Curr Top Med Chem; 2012; 12(21):2375-92. PubMed ID: 23279177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia.
    Abi-Dargham A; Moore H
    Neuroscientist; 2003 Oct; 9(5):404-16. PubMed ID: 14580124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical brain imaging investigations of schizophrenia.
    Soares JC; Innis RB
    Biol Psychiatry; 1999 Sep; 46(5):600-15. PubMed ID: 10472414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography.
    Ito H; Takahashi H; Arakawa R; Takano H; Suhara T
    Neuroimage; 2008 Jan; 39(2):555-65. PubMed ID: 17962043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.
    Laruelle M; Abi-Dargham A; van Dyck C; Gil R; D'Souza DC; Krystal J; Seibyl J; Baldwin R; Innis R
    Biol Psychiatry; 2000 Mar; 47(5):371-9. PubMed ID: 10704949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients.
    Knable MB; Hyde TM; Herman MM; Carter JM; Bigelow L; Kleinman JE
    Biol Psychiatry; 1994 Dec; 36(12):827-35. PubMed ID: 7893846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PET (positron emission tomography) research on schizophrenia].
    Takano A; Suhara T
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):177-83. PubMed ID: 16971782
    [No Abstract]   [Full Text] [Related]  

  • 8. Postmortem neurochemistry in schizophrenia.
    Bracha HS; Kleinman JE
    Psychiatr Clin North Am; 1986 Mar; 9(1):133-41. PubMed ID: 2421270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
    Gross NB; Duncker PC; Marshall JF
    Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptors and transporters in Parkinson's disease and schizophrenia.
    Seeman P; Niznik HB
    FASEB J; 1990 Jul; 4(10):2737-44. PubMed ID: 2197154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional neuroanatomy of the ventral striopallidal GABA pathway. New sites of intervention in the treatment of schizophrenia.
    O'Connor WT
    J Neurosci Methods; 2001 Aug; 109(1):31-9. PubMed ID: 11489297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the dopamine transporter-dopamine D2 receptor interaction in schizophrenia.
    Lee FJ; Pei L; Liu F
    Synapse; 2009 Aug; 63(8):710-2. PubMed ID: 19391151
    [No Abstract]   [Full Text] [Related]  

  • 13. Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia.
    Hirvonen J; van Erp TG; Huttunen J; Någren K; Huttunen M; Aalto S; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
    Psychiatry Res; 2006 Jan; 146(1):13-20. PubMed ID: 16361088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of dopamine and serotonin transmission in schizophrenia.
    Remington G
    Prog Brain Res; 2008; 172():117-40. PubMed ID: 18772030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal striatal dopamine transmission in schizophrenia.
    Brunelin J; Fecteau S; Suaud-Chagny MF
    Curr Med Chem; 2013; 20(3):397-404. PubMed ID: 23157632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
    Kegeles LS; Abi-Dargham A; Frankle WG; Gil R; Cooper TB; Slifstein M; Hwang DR; Huang Y; Haber SN; Laruelle M
    Arch Gen Psychiatry; 2010 Mar; 67(3):231-9. PubMed ID: 20194823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
    Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical imaging in schizophrenia.
    Urban N; Abi-Dargham A
    Curr Top Behav Neurosci; 2010; 4():215-42. PubMed ID: 21312402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.